(2R,5S,8S,14S,17S)-17-((S)-4-amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-8-(3-aminopropyl)-5-(carboxymethyl)-14-((R)-1-hydroxyethyl)-2-methyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecane-1,19-dioic acid
Daptomycin Impurity 9 is a fully characterized chemical compound used as a reference standard of API Daptomycin. The standard offered is compliant with regulatory guidelines. Daptomycin Impurity 9 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - N/A
Related products
Daptomycin Impurity 33 (Daptomycin beta-isomer diastereomer, Acetate Salt)
M.F. -
M.W. 1620.69; 59.04
CAT# AR-D06105
CAS# NA
Daptomycin Impurity 28 (linear Daptomycin impurity, Acetate Salt)
M.F.
M.W. 1638.71; 59.04
CAT# AR-D06100
CAS# NA
